A Law Firm Representing Injured People
Enter your phone number (no dashes) and we'll call you now.
1-866-9-4EDGAR
Toll Free 24/7 (1-866-943-3427)

Other posts in Ketek

Feb
2007
Antibiotic Ketek Gets FDA Warning Label
Jul
2006
FDA officials disagreed with Ketek's approval
Jun
2006
Liver damage warning put on Ketek drug label
May
2006
FDA panel pushes for stronger warning on Ketek
May
2006
Ketek approved despite flawed study
Edgar Snyder & Associates Free Legal Consulation Edgar Snyder & Associates Free Legal Consulation

Fill out this form to get a free legal evaluation. A legal expert will examine your situation to see if you have a case.

Personal Information

First Name

Last Name

City

State

ZIP

Phone #

Email

Age

Is an attorney currently handling this case?

Yes
No

Injury Information

Briefly describe your injuries

Privacy Policy & Legal Disclaimer

FDA Officials Disagreed with Ketek Approval

July 2006

A Food and Drug Administration (FDA) debate is heating up over the safety of the antibiotic, Ketek. According to internal FDA e-mails, Ketek’s approval was a mistake and the drug should be taken off the market immediately.

An FDA spokeswoman reassured that every issue or question raised during Ketek’s trial and afterward was reviewed by the nation’s top doctors both internally and externally. However, several e-mails have appeared stating that many safety officials within the FDA expressed serious concern with the antibiotic.

Since Ketek’s approval in 2004:

  • 14 adults suffered liver failure
  • Four of the fourteen died
  • others suffered serious liver injury

Although Ketek’s label has been changed to include a warning about severe liver damage, it is still is available for use. This is despite suggestions by officials to remove the antibiotic from the market.

Drug litigation may involve co-counsel.

Source: “Approval of Antibiotic Worried Safety Officials.” By Gardiner Harris. New York Times. July 19, 2006.
Awards

Edgar Snyder & Associates has received some of the highest distinctions awarded to attorneys & law firms. Click a logo to learn more: